Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

• मुख्य लेखकों: André B. Kind (लेखक), Andrew Pavelyev (लेखक), Smita Kothari (लेखक), Nadia El Mouaddin (लेखक), Aurélie Schmidt (लेखक), Edith Morais (लेखक), Patrik Guggisberg (लेखक), Florian Lienert (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2020-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background An infection with high-risk human papillomavirus (HPV) is the obligatory aetiological factor for the development of cervical cancer. In Switzerland, the prevention strategy for cervical cancer is based on primary prevention via HPV vaccination and secondary prevention with an opp...